imipramine has been researched along with Parkinsonian Disorders in 11 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pretreatment of rotenone groups with AMI or IMI prevented rotenone-induced neuronal degeneration and increased striatal dopamine level with motor recovery." | 1.43 | Imipramine and amitriptyline ameliorate the rotenone model of Parkinson's disease in rats. ( Abdelkader, NF; El-Sayeh, BM; Kandil, EA; Saleh, S, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (81.82) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, KS | 2 |
| Kang, YM | 1 |
| Kang, Y | 1 |
| Park, TS | 1 |
| Park, HY | 1 |
| Kim, YJ | 1 |
| Han, BS | 1 |
| Kim, CH | 1 |
| Lee, CH | 1 |
| Ardayfio, PA | 1 |
| Han, PL | 1 |
| Jung, BH | 1 |
| Kandil, EA | 1 |
| Abdelkader, NF | 1 |
| El-Sayeh, BM | 1 |
| Saleh, S | 1 |
| DENMARK, JC | 1 |
| DAVID, JD | 1 |
| McCOMB, SG | 1 |
| PAKKENBERG, H | 1 |
| GILLINGHAM, FJ | 2 |
| KALYANARAMAN, S | 1 |
| BOHACEK, N | 1 |
| HAJNSEK, F | 1 |
| SARTORIUS, N | 1 |
| BARUK, H | 1 |
| LAUNAY, J | 1 |
| SEGERS, J | 1 |
| SCHUNZELAAR, K | 1 |
| NUYTS, SA | 1 |
| SMYTHIES, JR | 1 |
| STRANG, RR | 1 |
| LIM, H | 1 |
| TAN, K | 1 |
11 other studies available for imipramine and Parkinsonian Disorders
| Article | Year |
|---|---|
Pitx3 deficient mice as a genetic animal model of co-morbid depressive disorder and parkinsonism.
Topics: Anhedonia; Animals; Antidepressive Agents; Brain; Comorbidity; Corticosterone; Depressive Disorder; | 2014 |
Imipramine and amitriptyline ameliorate the rotenone model of Parkinson's disease in rats.
Topics: Amitriptyline; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Antiparkinson Agents; | 2016 |
Imipramine hydrochloride (Tofranil) in Parkinsonism. A preliminary report.
Topics: Imipramine; Parkinson Disease; Parkinsonian Disorders; Psychopharmacology | 1961 |
[Pathogenesis and medical treatment of parkinsonism].
Topics: Humans; Imipramine; Parkinson Disease; Parkinsonian Disorders; Piperidines; Trihexyphenidyl | 1963 |
PARKINSON'S DISEASE.
Topics: Amitriptyline; Dextroamphetamine; Humans; Imipramine; Muscle Relaxants, Central; Neurosurgery; Orphe | 1963 |
[EXTRAPYRAMIDAL SYMPTOMS DUE TO THE USE OF PSYCHOPHARMACA].
Topics: Chlorpromazine; Chlorprothixene; Extrapyramidal Tracts; Fluphenazine; Imipramine; Methotrimeprazine; | 1963 |
[NEUROLEPTICS AND THE LAW OF STAGES].
Topics: Antipsychotic Agents; Catalepsy; Catatonia; Chlorpromazine; Epilepsy; Humans; Imipramine; Parkinsoni | 1964 |
REPORT ON THE TREATMENT OF PSYCHOTIC PATIENTS WITH SORDINOL.
Topics: Adolescent; Clopenthixol; Humans; Imipramine; Parkinsonian Disorders; Psychotic Disorders; Schizophr | 1964 |
A CASE OF POSTENCEPHALITIC PARKINSONISM RESPONDING TO COMBINED SURGICAL AND MEDICINAL TREATMENT.
Topics: Amitriptyline; Chlordiazepoxide; Depression; Depressive Disorder; Drug Therapy; Encephalitis; Eye Mo | 1965 |
IMIPRAMINE IN TREATMENT OF PARKINSONISM: A DOUBLE-BLIND PLACEBO STUDY.
Topics: Biomedical Research; Double-Blind Method; Drug Therapy; Imipramine; Parkinsonian Disorders; Placebos | 1965 |
[Treatment of Parkinson syndroms with tofranil].
Topics: Humans; Imipramine; Parkinson Disease; Parkinsonian Disorders | 1961 |